Cargando…

Long-term worsening of different body functions in persons with progressive multiple sclerosis

BACKGROUND: It is unclear whether EDSS is responsive to disability worsening in advanced MS. OBJECTIVE: To explore the dynamics of disability worsening in persons with advanced-stage MS (EDSS ≥5.5) using three disability worsening definitions (EDSS, Rivermead Mobility Index (RMI), 9-Hole Peg Test (9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufmann, Marco, Vaney, Claude, Barin, Laura, Liu, Xinglu, von Wyl, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557796/ https://www.ncbi.nlm.nih.gov/pubmed/33110620 http://dx.doi.org/10.1177/2055217320964514

Ejemplares similares

Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study
por: Sieber, Chloé, et al.
Publicado: (2022)

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis
por: Devolder, Lindsay, et al.
Publicado: (2023)

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
por: Rodgers, Stephanie, et al.
Publicado: (2021)

Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
por: Stanikić, Mina, et al.
Publicado: (2023)

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis
por: Kaufmann, Marco, et al.
Publicado: (2019)

60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments
por: Kaufmann, Marco, et al.
Publicado: (2020)

Non-equivalent, but still valid: Establishing the construct validity of a consumer fitness tracker in persons with multiple sclerosis
por: Polhemus, Ashley, et al.
Publicado: (2023)

Feasibility and scalability of a fitness tracker study: Results from a longitudinal analysis of persons with multiple sclerosis
por: Sieber, Chloé, et al.
Publicado: (2023)

Factors associated with employment and expected work retention among persons with multiple sclerosis: findings of a cross-sectional citizen science study
por: Lehmann, Anja I., et al.
Publicado: (2020)

How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis
por: Barin, Laura, et al.
Publicado: (2019)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors
por: Ajdacic-Gross, Vladeta, et al.
Publicado: (2021)

A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod
por: Salter, Amber, et al.
Publicado: (2021)

Proximity to death and health care expenditure increase revisited: A 15-year panel analysis of elderly persons
por: von Wyl, Viktor
Publicado: (2019)

Severity and worsening of fatigue among individuals with multiple sclerosis
por: Salter, Amber, et al.
Publicado: (2023)

Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland
por: Kaufmann, Marco, et al.
Publicado: (2018)

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study
por: Miller, David H., et al.
Publicado: (2018)

Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability
por: Studer, Valeria, et al.
Publicado: (2017)

Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes
por: Colato, Elisa, et al.
Publicado: (2021)

Erratum to “A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod”
Publicado: (2021)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

Multiple sclerosis presenting initially with a worsening of migraine symptoms
por: Lin, Guan-Yu, et al.
Publicado: (2013)

Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients
por: Roura, Eloy, et al.
Publicado: (2021)

Deep gray matter volume loss drives disability worsening in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
por: Brune, Synne, et al.
Publicado: (2022)

Case report: Pragmatic impairment in multiple sclerosis after worsening of clinical symptoms
por: Lago, Sara, et al.
Publicado: (2022)

Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis
por: Hoepner, Robert, et al.
Publicado: (2022)

Methodological heterogeneity biases physical activity metrics derived from the Actigraph GT3X in multiple sclerosis: A rapid review and comparative study
por: Polhemus, Ashley, et al.
Publicado: (2022)

The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing
por: Chiavi, Deborah, et al.
Publicado: (2022)

Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures
por: Gaetani, Lorenzo, et al.
Publicado: (2022)

COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
por: Conway, Sarah E., et al.
Publicado: (2022)

Corrigendum: Case report: Pragmatic impairment in multiple sclerosis after worsening of clinical symptoms
por: Lago, Sara, et al.
Publicado: (2023)

Natalizumab in Multiple Sclerosis: Long-Term Management
por: Clerico, Marinella, et al.
Publicado: (2017)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis
por: Galea, I, et al.
Publicado: (2013)

Blending citizen science with natural language processing and machine learning: Understanding the experience of living with multiple sclerosis
por: Haag, Christina, et al.
Publicado: (2023)

Challenges for Nontechnical Implementation of Digital Proximity Tracing During the COVID-19 Pandemic: Media Analysis of the SwissCovid App
por: von Wyl, Viktor
Publicado: (2021)

Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies
por: Hunter, Samuel F., et al.
Publicado: (2021)

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening
por: Phillips, Glenn A, et al.
Publicado: (2014)

Does a modifiable risk factor score predict disability worsening in people with multiple sclerosis?
por: Marck, Claudia H, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ph3f3r7g6k645qki7r1u4gguda